Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of aging on treatment considerations for multiple sclerosis patients
Gabrielle Macaron, Catherine Larochelle, Nathalie Arbour, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 21

Showing 21 citing articles:

The ageing central nervous system in multiple sclerosis: the imaging perspective
Massimo Filippi, Paolo Preziosa, Frederik Barkhof, et al.
Brain (2024) Vol. 147, Iss. 11, pp. 3665-3680
Open Access | Times Cited: 6
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review
Óscar Fernández, Per Soelberg Sørensen, Gıancarlo Comı, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Peripheral blood age-sensitive immune markers in multiple sclerosis: relation to sex, cytomegalovirus status, and treatment
Haritha L. Desu, Renaud Balthazard, Audrey Daigneault, et al.
EBioMedicine (2025) Vol. 112, pp. 105559-105559
Open Access
Multiple Sclerosis. Some Features of Pathology and Prospects for Therapy. Part 2
Fetisova Ek, N.V. Vorobjeva, Maria S. Muntyan
Advances in Gerontology (2025)
Closed Access
Transcranial direct current stimulation for cognitive rehabilitation in people with multiple sclerosis: A systematic review of randomized controlled trials
Anas R. Alashram
Applied Neuropsychology Adult (2025), pp. 1-12
Closed Access
Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain
Pedro Oliva‐Nacarino, Marina Simal Antuña, Carmen Santos Varela, et al.
BMC Neurology (2025) Vol. 25, Iss. 1
Open Access
Global, regional, and national burden of tobacco-related neurological disorders from 1990 to 2021: Trends and future projections
Chenyang Zhang, Zhiqiang An, Jingkui Jiang, et al.
Tobacco Induced Diseases (2025) Vol. 23, Iss. March, pp. 1-11
Open Access
As time goes by: Treatment challenges in elderly people with multiple sclerosis
Stefano Gelibter, Lorenzo Saraceno, Fiammetta Pirro, et al.
Journal of Neuroimmunology (2024) Vol. 391, pp. 578368-578368
Closed Access | Times Cited: 3
Association of Higher Mediterranean Diet Adherence With Lower Prevalence of Disability and Symptom Severity, Depression, Anxiety, Stress, Sleep Quality, Cognitive Impairment, and Physical Inactivity in Older Adults With Multiple Sclerosis
Christina Tryfonos, Eleni Pavlidou, Theofanis Vorvolakos, et al.
Journal of Geriatric Psychiatry and Neurology (2023) Vol. 37, Iss. 4, pp. 318-331
Closed Access | Times Cited: 9
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA)
Clara Grazia Chisari, Maria Pia Amato, Alessia Di Sapio, et al.
Journal of Neurology (2024) Vol. 271, Iss. 10, pp. 6801-6810
Open Access | Times Cited: 2
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis
Lorraine V. Kalia, Angelica Asis, Nathalie Arbour, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 12, pp. 724-737
Closed Access | Times Cited: 2
Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple Sclerosis
Friederike Held, Christine Makarov, Christiane Gasperi, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 12, Iss. 1
Closed Access | Times Cited: 2
De-escalation and Discontinuation of Disease-Modifying Therapies in Multiple Sclerosis
Robert Gross, John R. Corboy
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 9, pp. 341-353
Closed Access | Times Cited: 2
Association of Mediterranean diet adherence with disease progression, quality of life and physical activity, sociodemographic and anthropometric parameters, and serum biomarkers in community-dwelling older adults with multiple sclerosis: a cross-sectional study
Christina Tryfonos, Maria Chrysafi, Sousana Κ. Papadopoulou, et al.
Aging Clinical and Experimental Research (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 1
Understanding the Complex Dynamics of Immunosenescence in Multiple Sclerosis: From Pathogenesis to Treatment
Monica Neațu, Ana Hera-Drăguț, Iulia Ioniță, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1890-1890
Open Access
Comprehensive Analysis of Multiple Sclerosis Hospitalization Trends in Spain (1998-2022)
Lucía Cayuela, Cristina García‐Muñoz, Aurelio Cayuela
Multiple Sclerosis and Related Disorders (2024) Vol. 91, pp. 105887-105887
Closed Access
Strategic De-escalation of Disease-Modifying Therapies in Elderly Patients: Approaches and Considerations
Robert Gross, John R. Corboy
Current Treatment Options in Neurology (2024) Vol. 27, Iss. 1
Closed Access
Unveiling the fate and potential neuroprotective role of neural stem/progenitor cells in multiple sclerosis
Nora Hijal, Malak Fouani, Bassel Awada
Frontiers in Neurology (2024) Vol. 15
Open Access
Investigation of differences between chronological and vascular age in persons with multiple sclerosis
Gorica Marić, Tatjana Pekmezović, Olivera Tamaš, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0311117-e0311117
Open Access
Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain
Pedro Oliva‐Nacarino, Marina Simal Antuña, Carmen Santos Varela, et al.
Research Square (Research Square) (2024)
Closed Access
Dorsoventral photobiomodulation therapy safely reduces inflammation and sensorimotor deficits in a mouse model of multiple sclerosis
Vincent Escarrat, Davide Reato, Guillaume Blivet, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access
From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
Muhammad Faraz Raghib, Evanthia Bernitsas
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3069-3069
Open Access | Times Cited: 1
Page 1

Scroll to top